Faustman-Watts E M, Goodman J I
Biochem Pharmacol. 1984 Feb 15;33(4):585-90. doi: 10.1016/0006-2952(84)90312-5.
The investigations reported in this paper were designed to analyze the patterns of DNA-purine methylation in hepatic chromatin following in vivo exposure to the carcinogenic alkylating agents dimethylnitrosamine (DMN) or methylnitrosourea (MNU). Male Sprague-Dawley rats were exposed to [14C]DMN (8 mumoles, 1.0 microCi per mumole per 100 g) or [3H]MNU (15 mumoles, 10 microCi per mumole per 100 g) via gastric intubation. Hepatic chromatin was fractionated into portions having characteristics of template-active euchromatin (S2) and template-repressed heterochromatin (P2) by digestion with DNase II followed by MgCl2 precipitation. Specific DNA purines were identified at 24 hr post-intubation using an isocratic high pressure liquid chromatographic system. A qualitatively similar pattern of 7-methylguanine, O6-methylguanine, 1-methyladenine and 3-methyladenine alkylation was observed in DNA from total chromatin versus heterochromatin at 24 hr following exposure to either carcinogen. These assessments were made at times following carcinogen exposure which produced maximal quantitative differences in alkylation of euchromatin versus heterochromatin DNA. Similar patterns of DNA purine alkylation were observed in total chromatin and heterochromatin. These observations suggest that, once the reactive species is generated and access to chromatin DNA occurs, a similar pattern of DNA-purine alkylation is produced in different regions of the genome.
本文所报道的研究旨在分析体内暴露于致癌烷化剂二甲基亚硝胺(DMN)或甲基亚硝基脲(MNU)后肝脏染色质中DNA嘌呤甲基化模式。雄性Sprague-Dawley大鼠通过胃插管暴露于[14C]DMN(8微摩尔,每100克每微摩尔1.0微居里)或[3H]MNU(15微摩尔,每100克每微摩尔10微居里)。通过用DNase II消化,随后用MgCl2沉淀,将肝脏染色质分离成具有模板活性常染色质(S2)和模板抑制异染色质(P2)特征的部分。在插管后24小时,使用等度高压液相色谱系统鉴定特定的DNA嘌呤。在暴露于任何一种致癌物后24小时,在总染色质与异染色质的DNA中观察到7-甲基鸟嘌呤、O6-甲基鸟嘌呤、1-甲基腺嘌呤和3-甲基腺嘌呤烷基化的定性相似模式。这些评估是在致癌物暴露后进行的,此时常染色质与异染色质DNA的烷基化产生了最大的定量差异。在总染色质和异染色质中观察到相似的DNA嘌呤烷基化模式。这些观察结果表明,一旦产生活性物种并进入染色质DNA,基因组的不同区域就会产生相似的DNA嘌呤烷基化模式。